Investment sentiments improved after Moderna Inc reported a 94.5 per cent efficacy rate for its candidate mRNA-1273 on Monday on the back of its large, late-stage phase III COVE study.
from Commodities-Markets-Economic Times
Read The Rest:economictimes...
Post Top Ad
Tuesday 17 November 2020
Commodity strategies: Gold, silver, crude, base metals
Tags
# commodities
Share This
About ajit
commodities
Tags:
commodities
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment